ZNF548
gene geneOn this page
Also known as FLJ32932
Summary
ZNF548 (zinc finger protein 548, HGNC:26561) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 548 (Q8NEK5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 147694 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_001172773
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26561 |
| Approved symbol | ZNF548 |
| Name | zinc finger protein 548 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32932 |
| Ensembl gene | ENSG00000188785 |
| Ensembl biotype | protein_coding |
| Entrez | 147694 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 8 protein_coding, 3 nonsense_mediated_decay, 1 retained_intron
ENST00000336128, ENST00000366197, ENST00000594668, ENST00000594693, ENST00000596282, ENST00000597047, ENST00000597400, ENST00000597576, ENST00000598895, ENST00000600442, ENST00000600927, ENST00000602086
RefSeq mRNA: 2 — MANE Select: NM_001172773
NM_001172773, NM_152909
CCDS: CCDS46209, CCDS54324
Canonical transcript exons
ENST00000336128 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003055153 | 57389854 | 57390114 |
| ENSE00003534399 | 57397048 | 57397174 |
| ENSE00003552707 | 57394188 | 57394223 |
| ENSE00004282245 | 57398430 | 57402992 |
Expression profiles
Bgee: expression breadth ubiquitous, 266 present calls, max score 97.69.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.2758 / max 128.3385, expressed in 1761 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177770 | 7.2927 | 1713 |
| 177771 | 2.9831 | 975 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gingival epithelium | UBERON:0001949 | 97.69 | gold quality |
| buccal mucosa cell | CL:0002336 | 96.55 | gold quality |
| superficial temporal artery | UBERON:0001614 | 96.33 | gold quality |
| gingiva | UBERON:0001828 | 95.11 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 93.43 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.38 | gold quality |
| cardia of stomach | UBERON:0001162 | 93.07 | gold quality |
| lower lobe of lung | UBERON:0008949 | 89.44 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 88.06 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 87.28 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 86.81 | gold quality |
| ventral tegmental area | UBERON:0002691 | 86.49 | gold quality |
| secondary oocyte | CL:0000655 | 86.33 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 86.24 | gold quality |
| biceps brachii | UBERON:0001507 | 85.96 | gold quality |
| vena cava | UBERON:0004087 | 85.73 | gold quality |
| cauda epididymis | UBERON:0004360 | 85.34 | gold quality |
| upper leg skin | UBERON:0004262 | 85.25 | gold quality |
| heart right ventricle | UBERON:0002080 | 85.16 | gold quality |
| lymph node | UBERON:0000029 | 85.15 | gold quality |
| tonsil | UBERON:0002372 | 84.88 | gold quality |
| colonic epithelium | UBERON:0000397 | 84.81 | gold quality |
| body of tongue | UBERON:0011876 | 84.75 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 84.55 | gold quality |
| superior surface of tongue | UBERON:0007371 | 84.51 | gold quality |
| omental fat pad | UBERON:0010414 | 84.49 | gold quality |
| peritoneum | UBERON:0002358 | 84.46 | gold quality |
| mammary duct | UBERON:0001765 | 84.43 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 84.39 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 84.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
130 targeting ZNF548, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zfx | ENSDARG00000074453 |
| danio_rerio | ENSDARG00000098424 | |
| mus_musculus | Zfy2 | ENSMUSG00000000103 |
| mus_musculus | Zfy1 | ENSMUSG00000053211 |
| rattus_norvegicus | Zfy1 | ENSRNOG00000053042 |
Paralogs (38): ZFX (ENSG00000005889), ZBTB11 (ENSG00000066422), ZFAT (ENSG00000066827), ZFY (ENSG00000067646), ZNF586 (ENSG00000083828), IKZF5 (ENSG00000095574), ZNF419 (ENSG00000105136), ZNF549 (ENSG00000121406), ZSCAN20 (ENSG00000121903), ZNF304 (ENSG00000131845), PRDM15 (ENSG00000141956), ZNF660 (ENSG00000144792), ZNF711 (ENSG00000147180), ZNF773 (ENSG00000152439), ZNF256 (ENSG00000152454), ZNF837 (ENSG00000152475), ZNF691 (ENSG00000164011), ZNF610 (ENSG00000167554), E4F1 (ENSG00000167967), ZNF562 (ENSG00000171466), ZNF561 (ENSG00000171469), ZNF584 (ENSG00000171574), ZIK1 (ENSG00000171649), ZNF570 (ENSG00000171827), ZSCAN2 (ENSG00000176371), ZNF552 (ENSG00000178935), ZNF154 (ENSG00000179909), ZNF792 (ENSG00000180884), ZNF793 (ENSG00000188227), ZNF79 (ENSG00000196152), ZNF418 (ENSG00000196724), ZNF772 (ENSG00000197128), ZNF583 (ENSG00000198440), ZNF480 (ENSG00000198464), ZNF551 (ENSG00000204519), ZNF134 (ENSG00000213762), ZNF587B (ENSG00000269343), ZNF8 (ENSG00000278129)
Protein
Protein identifiers
Zinc finger protein 548 — Q8NEK5 (reviewed: Q8NEK5)
All UniProt accessions (10): Q8NEK5, M0QX17, M0QXE2, M0QY53, M0QYA3, M0R041, M0R1K1, M0R2J6, M0R354, M0R3F2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NEK5-1 | 1 | yes |
| Q8NEK5-2 | 2 |
RefSeq proteins (2): NP_001166244, NP_690873 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050527 |
Pfam: PF00096, PF01352
UniProt features (18 total): zinc finger region 11, sequence variant 2, chain 1, domain 1, cross-link 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEK5-F1 | 67.04 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 516
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 59 (showing top):
WANG_CLIM2_TARGETS_UP, PEREZ_TP63_TARGETS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, FEVR_CTNNB1_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, UBN1_TARGET_GENES, ZFP91_TARGET_GENES, ZNF577_TARGET_GENES, MIR5688, MIR495_3P, MIR4728_5P, MIR15A_5P, MIR195_5P, MIR15B_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
412 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF548 | ZNF385B | Q569K4 | 561 |
| ZNF548 | TSHZ3 | Q63HK5 | 456 |
| ZNF548 | YIF1A | O95070 | 368 |
| ZNF548 | APMAP | Q9HDC9 | 360 |
| ZNF548 | MYG1 | Q9HB07 | 352 |
| ZNF548 | DDX19A | Q9NUU7 | 349 |
| ZNF548 | BCAP29 | Q9UHQ4 | 336 |
| ZNF548 | CWF19L2 | Q2TBE0 | 320 |
| ZNF548 | USP33 | Q8TEY7 | 317 |
| ZNF548 | POGZ | Q7Z3K3 | 308 |
| ZNF548 | PFDN5 | Q99471 | 305 |
| ZNF548 | ANAPC7 | Q9UJX3 | 305 |
| ZNF548 | PRKAB2 | O43741 | 294 |
| ZNF548 | TTK | P33981 | 290 |
| ZNF548 | CSTF1 | Q05048 | 287 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRC36 | TBL1X | psi-mi:“MI:0914”(association) | 0.350 |
| DISC1 | ZNF548 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NDEL1 | ZNF548 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): ZNF548 (Affinity Capture-MS), ZNF548 (Affinity Capture-MS), ZNF548 (Affinity Capture-MS), ZNF548 (Affinity Capture-MS), ZNF548 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1141 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57390704:T:A | acceptor_gain | 1.0000 |
| 19:57397038:A:AG | acceptor_gain | 1.0000 |
| 19:57390001:G:GG | donor_gain | 0.9900 |
| 19:57390110:CTGAG:C | donor_loss | 0.9900 |
| 19:57390111:TGAGG:T | donor_loss | 0.9900 |
| 19:57390115:G:GA | donor_loss | 0.9900 |
| 19:57390116:T:A | donor_loss | 0.9900 |
| 19:57394186:AG:A | acceptor_gain | 0.9900 |
| 19:57394187:GG:G | acceptor_gain | 0.9900 |
| 19:57397038:AATTT:A | acceptor_gain | 0.9900 |
| 19:57397039:A:G | acceptor_gain | 0.9900 |
| 19:57397042:T:TA | acceptor_gain | 0.9900 |
| 19:57397042:TGGCA:T | acceptor_loss | 0.9900 |
| 19:57397043:G:A | acceptor_gain | 0.9900 |
| 19:57397045:CA:C | acceptor_loss | 0.9900 |
| 19:57397046:A:AG | acceptor_gain | 0.9900 |
| 19:57397046:A:T | acceptor_loss | 0.9900 |
| 19:57397046:AG:A | acceptor_gain | 0.9900 |
| 19:57397047:G:GG | acceptor_gain | 0.9900 |
| 19:57397047:GG:G | acceptor_gain | 0.9900 |
| 19:57397047:GGGCC:G | acceptor_gain | 0.9900 |
| 19:57397173:AGGT:A | donor_loss | 0.9900 |
| 19:57397173:AGGTA:A | donor_loss | 0.9900 |
| 19:57397174:GGT:G | donor_loss | 0.9900 |
| 19:57397176:TAA:T | donor_loss | 0.9900 |
| 19:57389998:GGA:G | donor_gain | 0.9800 |
| 19:57389999:GAG:G | donor_gain | 0.9800 |
| 19:57394222:AGGT:A | donor_loss | 0.9800 |
| 19:57394222:AGGTG:A | donor_loss | 0.9800 |
| 19:57394224:G:A | donor_loss | 0.9800 |
AlphaMissense
3664 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57399659:T:C | F458L | 0.999 |
| 19:57399661:T:A | F458L | 0.999 |
| 19:57399661:T:G | F458L | 0.999 |
| 19:57399594:T:C | L436P | 0.997 |
| 19:57399743:T:C | F486L | 0.997 |
| 19:57399745:T:A | F486L | 0.997 |
| 19:57399745:T:G | F486L | 0.997 |
| 19:57399575:T:C | F430L | 0.995 |
| 19:57399577:T:A | F430L | 0.995 |
| 19:57399577:T:G | F430L | 0.995 |
| 19:57399604:T:A | H439Q | 0.995 |
| 19:57399604:T:G | H439Q | 0.995 |
| 19:57399616:C:A | H443Q | 0.995 |
| 19:57399616:C:G | H443Q | 0.995 |
| 19:57399491:T:C | F402L | 0.994 |
| 19:57399493:T:A | F402L | 0.994 |
| 19:57399493:T:G | F402L | 0.994 |
| 19:57399660:T:C | F458S | 0.994 |
| 19:57399520:C:A | H411Q | 0.993 |
| 19:57399520:C:G | H411Q | 0.993 |
| 19:57399678:T:C | L464P | 0.993 |
| 19:57399688:C:A | H467Q | 0.993 |
| 19:57399688:C:G | H467Q | 0.993 |
| 19:57399690:A:C | Q468P | 0.993 |
| 19:57399762:T:C | L492P | 0.993 |
| 19:57399602:C:G | H439D | 0.992 |
| 19:57399610:A:C | R441S | 0.992 |
| 19:57399610:A:T | R441S | 0.992 |
| 19:57399629:C:T | P448S | 0.991 |
| 19:57399686:C:G | H467D | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000012483 (19:57394534 A>G), RS1000246240 (19:57401155 T>G), RS1000289195 (19:57393894 T>C), RS1000591951 (19:57400726 C>T), RS1000979745 (19:57389973 G>A), RS1000993457 (19:57389041 A>G), RS1001032452 (19:57391355 C>T), RS1001090888 (19:57396394 G>A), RS1001264904 (19:57389793 A>G), RS1001341831 (19:57395164 T>C), RS1001698991 (19:57393003 C>T), RS1001785626 (19:57393397 A>C), RS1002131656 (19:57400676 G>A), RS1002340005 (19:57399839 C>G), RS1002396580 (19:57394570 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 4 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 3 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Dieldrin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW62 | HEK293 eGFP-ZNF548 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.